Postoperative results of minimally invasive direct coronary artery bypass procedure in 234 patients.
hybrid procedure
left anterior descending
minimally invasive
minithoracotomy
off-pump surgery
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
09
2022
accepted:
22
12
2022
entrez:
27
1
2023
pubmed:
28
1
2023
medline:
28
1
2023
Statut:
epublish
Résumé
Minimally invasive approach in cardiac surgery has gained popularity. In order to reduce surgical trauma in coronary surgery minimally invasive direct coronary artery bypass (MIDCAB) has already been established. This technique has been introduced for revascularisation of isolated left anterior descending (LAD). It can also be performed for hybrid revascularisation procedure in multi-vessel disease. From 2017 to 2021, 234 patients received MIDCAB operation in our heartcenter 73% were male. Most of the patients had two or three vessel disease (74%). The average age of the patients was 66 ± 12 years mean. The left internal mammary artery (LIMA) was anastomosed to the LAD through left minithoracotomy approach. Multi-vessel MIDCAB (MV-MIDCAB) including two anastomoses (T-graft to LIMA with additional saphenous vein graft) was done in 15% ( The average operation time was 2.3 ± 0.8 h mean. The 30-day mortality was 1.7% ( The MIDCAB procedure is a safe and less traumatic procedure for selected patients with proximal LAD lesions. It is also an option for hybrid procedure in multi-vessel disease. The ICU stay and application of pRBC's are low. Our MIDCAB results show a good postoperative clinical outcome. However, follow-up data are necessary to evaluate long-term outcome.
Identifiants
pubmed: 36704468
doi: 10.3389/fcvm.2022.1051105
pmc: PMC9871774
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1051105Informations de copyright
Copyright © 2023 Monsefi, Alaj, Sirat and Bakhtiary.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Thorac Cardiovasc Surg. 1967 Oct;54(4):535-44
pubmed: 6051440
J Am Coll Cardiol. 2014 Dec 30;64(25):2717-26
pubmed: 25541122
Wideochir Inne Tech Maloinwazyjne. 2017 Sep;12(3):285-290
pubmed: 29062450
Interact Cardiovasc Thorac Surg. 2019 Feb 1;28(2):206-213
pubmed: 30101313
Curr Opin Cardiol. 2015 Nov;30(6):643-9
pubmed: 26447502
Ann Thorac Surg. 1996 Jun;61(6):1658-63; discussion 1664-5
pubmed: 8651765
Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S79-82
pubmed: 10536955
HSR Proc Intensive Care Cardiovasc Anesth. 2011;3(4):249-53
pubmed: 23440055
Interv Cardiol. 2021 May 19;16:e08
pubmed: 34295373
Eur J Cardiothorac Surg. 2020 Jan 1;57(1):18-27
pubmed: 31219544
Ann Thorac Surg. 1997 Dec;64(6):1648-53; discussion 1654-5
pubmed: 9436550
Int J Cardiol Heart Vasc. 2021 Dec 01;37:100916
pubmed: 34917749
Curr Opin Cardiol. 2013 Nov;28(6):639-45
pubmed: 24077608
Ann Thorac Cardiovasc Surg. 2019 Aug 20;25(4):200-204
pubmed: 30842359
Heart Surg Forum. 2002;5(2):157-62
pubmed: 12114131
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
JACC Cardiovasc Interv. 2013 Jan;6(1):20-6
pubmed: 23347858
J Card Surg. 2004 Jan-Feb;19(1):12-6
pubmed: 15108783
BMJ. 2007 Mar 24;334(7594):617
pubmed: 17337458
Med Sci Monit. 2017 Mar 03;23:1123-1128
pubmed: 28257412